Funding
← Back to your selection

RA Capital Management

Activity from announced rounds

Activity in this selectionEnterprise software

RA Capital Management founds, funds and scales companies in healthcare and planetary health, combining scientific research with capital from seed through public-market financings.

Its TechAtlas research platform informs investment decisions through detailed scientific and market analysis. Raven, its healthcare incubator, works on originating and co-creating companies, giving researchers a route from a scientific idea to a funded business.

Blackbird provides a clinical development accelerator alongside the investment platform. These capabilities are relevant for founders who need to design a development programme and reach clinical milestones, as well as finance laboratory or commercial work.

Sources
Rounds participated in
6
Confirmed lead rounds
—
6 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$685.5M
6 disclosed · full round size, not this investor’s share

By stage

Series A2
Series B2
Growth1
Undisclosed1

By primary sector

Biotech5
Healthtech1

By country

United States6

Rounds

6 in this selection
Ollin Biosciences

Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD

$330MSeries B
Role not disclosed
NorthLinks Bio

Develops broad-spectrum antiviral prophylactic therapies for respiratory infections

$34MUndisclosed
Role not disclosed
Contraline

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries B
Role not disclosed
Secretome Therapeutics

Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy

$30MSeries A
Role not disclosed
NexCure

Provides CAR-T and other advanced treatment delivery in community outpatient settings

$19MSeries A
Role not disclosed